Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 52 Leukemia, Myeloid, Acute 47 Neoplasm Metastasis 43 Carcinoma, Non-Small-Cell Lung 38 Breast Neoplasms 37 Prostatic Neoplasms 34 Multiple Myeloma 30 Colorectal Neoplasms 27 Pancreatic Neoplasms 26 Melanoma 23 Carcinoma, Renal Cell 23 Ovarian Neoplasms 21 Lymphoma 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Burkitt Lymphoma 19 Triple Negative Breast Neoplasms 18 Myelodysplastic Syndromes 18 Lymphoma, Large B-Cell, Diffuse 17 Urinary Bladder Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Squamous Cell Carcinoma of Head and Neck 14 Glioblastoma 14 Fallopian Tube Neoplasms 14 Carcinoma, Hepatocellular 14 Oropharyngeal Neoplasms 13 Glioma 13 Sarcoma 12 Mouth Neoplasms 12 Carcinoma 12 Astrocytoma 12

Interventions

Specimen Handling 1 Diffusion Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Li-Fraumeni Syndrome × Specimen Handling × 90 days × Clear all

NCT04541654 2026-03-27

LiFT_UP

Dana-Farber Cancer Institute

Neoplastic Syndromes, Hereditary, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡